Overview

Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Study to assess the effect of rifampicin, ketoconazole and omeprazole on the pharmacokinetics of a single dose of Sativex and to evaluate the safety of Sativex when given in combination with these other drugs.
Phase:
Phase 1
Details
Lead Sponsor:
GW Pharmaceuticals Ltd.
Treatments:
Ketoconazole
Nabiximols
Omeprazole
Rifampin